Maria d'Apolito1,2, Daniela Pisanelli3, Flavio Faletra4, Ida Giardino5, Maddalena Gigante6, Massimo Pettoello-Mantovani3, Olivier Goulet7, Paolo Gasparini4, Angelo Campanozzi3. 1. Unit of Pediatrics, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. maria.dapolito@unifg.it. 2. Unit of Pediatrics, Department of Medical and Surgical Sciences, University of Foggia, viale Pinto, Foggia, Italy. maria.dapolito@unifg.it. 3. Unit of Pediatrics, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. 4. Institute for Maternal and Child Health-IRCCS "BurloGarofolo", Trieste, Italy. 5. Laboratory Medicine, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy. 6. Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy. 7. Department of Pediatric Gastroenterology-Hepatology and Nutrition and Reference Center for Rare Digestive Disease, Hopital Necker-Enfants Malades, Paris, France.
Abstract
BACKGROUND: Congenital tufting enteropathy (CTE), an inherited autosomal recessive rare disease, is a severe diarrhea of infancy which is clinically characterized by absence of inflammation and presence of intestinal villous atrophy. Mutations in the EpCAM gene were identified to cause CTE. Recent cases of syndromic tufting enteropathy harboring the SPINT2 (19q13.2) mutation were described. METHODS: Four CTE Italian patients were clinically and immunohistochemically characterized. Direct DNA sequencing of EpCAM and SPINT2 genes was performed. RESULTS: All patients were of Italian origin. Three different mutations were detected (p.Asp219Metfs*15, Tyr186Phefs*6 and p.Ile146Asn) in the EpCAM gene; one of them is novel (p.Ile146Asn). Two patients (P1 and P2) showed compound heterozygosity revealing two mutations in separate alleles. A third patient (P3) was heterozygous for only one novel EpCAM missense mutation (p.Ile146Asn). In a syndromic patient (P4), no deleterious EpCAM mutation was found. Additional SPINT2 mutational analysis was performed. P4 showed a homozygous SPINT2 mutation (p.Y163C). No SPINT2 mutation was found in P3. CLDN7 was also evaluated as a candidate gene by mutational screening in P3 but no mutation was identified. CONCLUSION: This study presented a molecular characterization of CTE Italian patients, and identified three mutations in the EpCAM gene and one in the SPINT2 gene. One of EpCAM mutations was novel, therefore increasing the mutational spectrum of allelic variants of the EpCAM gene. Molecular analysis of the SPINT2 gene also allowed us to identify a SPINT2 substitution mutation (c.488A>G) recently found to be associated with syndromic CTE subjects.
BACKGROUND:Congenital tufting enteropathy (CTE), an inherited autosomal recessive rare disease, is a severe diarrhea of infancy which is clinically characterized by absence of inflammation and presence of intestinal villous atrophy. Mutations in the EpCAM gene were identified to cause CTE. Recent cases of syndromic tufting enteropathy harboring the SPINT2 (19q13.2) mutation were described. METHODS: Four CTE Italian patients were clinically and immunohistochemically characterized. Direct DNA sequencing of EpCAM and SPINT2 genes was performed. RESULTS: All patients were of Italian origin. Three different mutations were detected (p.Asp219Metfs*15, Tyr186Phefs*6 and p.Ile146Asn) in the EpCAM gene; one of them is novel (p.Ile146Asn). Two patients (P1 and P2) showed compound heterozygosity revealing two mutations in separate alleles. A third patient (P3) was heterozygous for only one novel EpCAM missense mutation (p.Ile146Asn). In a syndromicpatient (P4), no deleterious EpCAM mutation was found. Additional SPINT2 mutational analysis was performed. P4 showed a homozygous SPINT2 mutation (p.Y163C). No SPINT2 mutation was found in P3. CLDN7 was also evaluated as a candidate gene by mutational screening in P3 but no mutation was identified. CONCLUSION: This study presented a molecular characterization of CTE Italian patients, and identified three mutations in the EpCAM gene and one in the SPINT2 gene. One of EpCAM mutations was novel, therefore increasing the mutational spectrum of allelic variants of the EpCAM gene. Molecular analysis of the SPINT2 gene also allowed us to identify a SPINT2 substitution mutation (c.488A>G) recently found to be associated with syndromicCTE subjects.
Authors: Markus Ladwein; Ulrich-Frank Pape; Dirk-Steffen Schmidt; Martina Schnölzer; Sabine Fiedler; Lutz Langbein; Werner W Franke; Gerhard Moldenhauer; Margot Zöller Journal: Exp Cell Res Date: 2005-10-01 Impact factor: 3.905
Authors: N Patey; J Y Scoazec; B Cuenod-Jabri; D Canioni; M Kedinger; O Goulet; N Brousse Journal: Gastroenterology Date: 1997-09 Impact factor: 22.682
Authors: Mamata Sivagnanam; Andreas R Janecke; Thomas Müller; Peter Heinz-Erian; Sharon Taylor; Lynne M Bird Journal: Clin Dysmorphol Date: 2010-01 Impact factor: 0.816
Authors: O Goulet; M Kedinger; N Brousse; B Cuenod; V Colomb; N Patey; S de Potter; J F Mougenot; D Canioni; N Cerf-Bensussan Journal: J Pediatr Date: 1995-08 Impact factor: 4.406
Authors: Kristin E Hirabayashi; Anthony T Moore; Bryce A Mendelsohn; Ryan J Taft; Aditi Chawla; Denise Perry; Duncan Henry; Anne Slavotinek Journal: Am J Med Genet A Date: 2018-04 Impact factor: 2.802
Authors: Dale L Bodian; Thierry Vilboux; Suchitra K Hourigan; Callie L Jenevein; Haresh Mani; Kathleen C Kent; Alina Khromykh; Benjamin D Solomon; Natalie S Hauser Journal: Cold Spring Harb Mol Case Stud Date: 2017-11-21
Authors: Sagar J Pathak; James L Mueller; Kevin Okamoto; Barun Das; Jozef Hertecant; Lynn Greenhalgh; Trevor Cole; Vered Pinsk; Baruch Yerushalmi; Odul E Gurkan; Michael Yourshaw; Erick Hernandez; Sandy Oesterreicher; Sandhia Naik; Ian R Sanderson; Irene Axelsson; Daniel Agardh; C Richard Boland; Martin G Martin; Christopher D Putnam; Mamata Sivagnanam Journal: Hum Mutat Date: 2018-11-29 Impact factor: 4.878